In a recent opinion piece, the author criticizes Donald Trump’s scientific policies, particularly highlighting his appointment of Robert Kennedy as Secretary of Health. The article claims that Kennedy, along with Marty Makary, head of the FDA, has been promoting leucovorin, a synthetic form of vitamin B9, as a treatment for autism without providing substantial evidence to support their claims. This has raised concerns among independent scientists who argue that such unsubstantiated treatments can be harmful and misleading.

The criticism stems from a broader apprehension regarding the administration’s approach to scientific integrity, especially in health-related matters. The author underscores that promoting remedies without scientific backing reflects poorly on the credibility of the government and can lead to dangerous misinformation being spread among vulnerable communities. This situation is particularly alarming for families affected by autism, who often seek genuine and scientifically proven support and treatment options.

The article ultimately calls for a return to evidence-based practices in health policy and a pushback against misinformation propagated by government officials. It emphasizes the importance of allowing qualified scientists to lead discussions on autism rather than politicians who might prioritize their agendas over the health and wellbeing of the public.